VIRACEPT 250 mg (Viracept 250 mg)
Generic Name: nelfinavir
Pill imprint VIRACEPT 250 mg has been identified as Viracept 250 mg.
Viracept is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Viracept 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- VIRACEPT 250 mg
- 250 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- ViiV Healthcare
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium silicate
FD&C Blue No. 2
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|54868-3947||Physicians Total Care Inc (repackager)|
|55289-0477||PDRX Pharmaceuticals Inc (repackager)|
|54569-4543||A-S Medication Solutions, LLC (repackager)|
|52959-0289||H.J. Harkins Company, Inc (repackager)|
|49999-0431||Lake Erie Medical and Surgical Supply (repackager)|
|66267-0514||Nucare Pharmaceuticals Inc (repackager)|
More about Viracept (nelfinavir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: protease inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.